A clinical study found that more glaucoma patients on BAK-preserved PGAs had elevated MMP9 in tears (>40 ng/mL) compared with those on BAK-free tafluprost (46.7% vs. 16.7%;p < 0.05) [22]. The gene discussed is MMP9; the disease is glaucoma.